Medical Advisory Board
Where the world’s leading clinical minds shape the future of medicine. Physicians, surgeons, nurses, psychiatrists, pharmacists, scientists and dentists setting the standard for clinical governance and protocols based on science and real-world expertise, so you can lead with confidence.

Bridging the Gap in Medicine
91% of physicians report having no formal training in regenerative protocols. MedBridge Global exists to solve this disparity. Our Advisory Board provides the clinical governance, standardized protocols, and evidence-based rigor required to elevate the standard of care globally.
Our Medical Advisory Board

Dr. Mark Giovanini, M.D.
Board-certified neurosurgeon and regenerative medicine leader who founded the Center for Life in Pensacola, Florida, a physician-led longevity centre. With more than two decades of clinical experience, Dr. GIO has helped thousands of patients through stem cell, peptide and exosome therapies that treat the root causes of ageing at the cellular level, and created Fitness Biostacking, which combines light, heat, oxygen and movement.

Dr. Daniel McGrath, D.O.
Fellowship-trained hair restoration surgeon, general surgeon by training, and founder of McGrath Medical in Austin, Houston, Dallas and San Antonio. A Diplomate and former President of the American Board of Hair Restoration Surgery and a Fellow of the ISHRS, he performs FUE and FUT and treats hair loss with extracellular vesicles. Named among the world’s best hair transplant surgeons by the American Hair Loss Council in 2026.

Dr. Nicole Graf, DPM, FACPM, C.Ped.
Quadruple board-certified podiatric physician and founder and CEO of Lexington Podiatry in Kentucky, with 19 years in practice. Her work spans biomechanics, orthotics, pedorthics, sports injuries and regenerative medicine. She is adjunct faculty at the University of Kentucky and MedBridge Global’s Medical Director of Podiatry.

Dr. Luis David Suarez, M.D.
UNAM-trained physician with more than 24 years in functional and integrative medicine and over 7,000 patients treated. Founder of Sanar Integrative in Polanco, Mexico City, and founding president of AMMCann, the Mexican Association of Cannabinoid Medicine. Further trained in acupuncture, ozone therapy, IV nutrition and stem cell therapies, and co-author of peer-reviewed research on the safety of cannabinoid medicine.

Vince Liguori
Biotech executive and CEO of L2 Bio and Ageless Biotech, developing minimally manipulated, tissue-based regenerative biologics for osteoarthritis under an FDA-approved IND. Board member and investor at Akan Biosciences, a cellular therapy company developing stem cell-based therapeutics.

Dr. Dominik Schaffner, M.D.
German board-certified orthopaedic and musculoskeletal trauma surgeon, accredited in Australia, Germany and the EU, specialising in regenerative and longevity medicine, biologics and orthopaedics. Over 15 years he has practised across Germany, Europe, South Africa, Australia and Asia-Pacific, with former academic appointments at UNSW and the Technical University of Munich. Based in Sydney with Biogenix, he speaks internationally and once represented Germany in sailing’s 49er class.

Dr. Gerry Curatola, D.D.S.
Pioneer of biologic dentistry with more than 40 years in practice and founder of Rejuvenation Dentistry in New York. Adjunct Clinical Associate Professor at NYU College of Dentistry, where he founded the Curatola Wing for Clinical Research. Developer of Revitin® prebiotic oral care, holder of three US patents, author of The Mouth-Body Connection, and trainer of more than 10,000 dentists in 12 countries.

Dr. Alexia McClerkin, D.C., APRN
Doctor of Chiropractic (Texas Chiropractic College) and board-certified family nurse practitioner, with nursing degrees from the University of Texas at Arlington and a kinesiology degree from Michigan State University. At The Sports and Wellness Doc in Houston she combines chiropractic care with regenerative and integrative treatments, including joint injections, ozone, hyperbaric oxygen and peptide therapy.

Dr. Baback Amen, M.D.
Board-certified anaesthesiologist who graduated in medicine with honours and trained in functional medicine with the Institute for Functional Medicine. He runs a personalised health-optimisation practice for executives and entrepreneurs, speaks internationally on longevity, including at the World Congress of Anti-Ageing Medicine in Monaco, and advises health and medical-technology ventures as an angel investor.

Dr. Elliot Lander, M.D.
Urologist and pioneer of regenerative urology with more than 30 years in practice in Rancho Mirage and Beverly Hills, California. Performing adipose-derived stem cell procedures since 2010, he co-founded the Cell Surgical Network in 2012 to train physicians worldwide, has published peer-reviewed research on stem cell safety and efficacy, and wrote The Stem Cell Revolution.

Hina Shahzadi, PharmD, MPhil, MSc
Doctorally trained pharmacist and research scientist specializing in pharmaceutical sciences, peptide pharmacology, and medication safety. Educator and curriculum developer focused on evidence-based regenerative medicine, clinical research, and patient safety.
The Board-Led Methodology
Peer-Reviewed Governance
Every protocol taught by MedBridge Global is vetted by our Advisory Board to ensure it meets the highest standards of safety and clinical evidence. We bridge the gap between “investigational” and “standard of care,” providing you with a legally and medically sound framework for your practice.
Specialist-Designed Curriculum
Our certifications in Peptides, Stem Cell Therapy, and IV Therapy are not generic. They are architected by our Board members-pioneering surgeons and functional specialists-to ensure the education you receive is immediately applicable to complex, real-world patient cases.
The Restorative Practice Roadmap
Beyond the science, our Board provides the strategic blueprints for the "Restorative Practice." We teach you how to integrate these high-tier services into your workflow, optimizing patient outcomes while increasing the average revenue per patient through a Medicine 3.0 model.